drugset
drugset / Trial / NCT03582332

Serum Creatinine Change / Renal Adverse Effect With Use of Non-steroidal Painkillers in Axial Spondyloarthritis Patients

NCT03582332 ↗

Phase 4 Completed 64 enrolled Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
RandomizedSequentialOpen-labelTreatment

Summary

2 Non-steroidal anti-inflammatory drugs (NSAIDs), indomethacin and etoricoxib were prescribed sequentially in Axial Spondyloarthritis patients according to the internationally accepted guidelines to determine serum creatinine change with NSAIDs use.

Timeline

Start
2016-01-02
Primary completion
2016-06-23
Completion
2016-06-23

Drugs

EvaluationDrugModalityDoseRoute
Comparator Etoricoxib Small molecule 60 mg Oral
Comparator Etoricoxib Small molecule 90 mg Oral
Comparator Indomethacin Small molecule 50 mg Oral
Comparator Indomethacin Small molecule 75 mg Oral

Indications

spondyloarthropathy